Skip to content

ACORN CAPITAL ADVISORS, LLC

Follow

13F filer, CIK 2054410, NEW YORK, NY

ACORN CAPITAL ADVISORS, LLC reported $363,951,897 across 22 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 87.99% of the portfolio.

Accepted , ingested 13F-HR 0001636587-26-000102

Period
2026-09-30
Reported value
$364M
Holdings
22
Top 10 weight
87.99%
New
2
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ANTXnew+1,300,000$6.92M
ENGNadded+2,540,525$5.08M
ANNXnew+1,136,974$4.81M
LONAadded+509,877$1.82M
VYNEadded+30,580$689K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
URGNreduced-25,000-$1.02M
WHWKreduced-207,224-$779K
KPTIreduced-296,094-$361K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001636587-26-000102, largest first. % of portfolio is the value over $363,951,897, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CGONCG ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,131,501 shares; 2025Q1: 1,131,501 shares; 2025Q2: 1,131,501 shares; 2025Q3: 1,131,501 shares; 2025Q4: 1,131,501 shares; 2026Q1: 1,130,501 shares; 2026Q2: 1,131,500 shares; 2026Q3: 1,131,500 shares 1,131,500$80.2M22.04%0Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,516,303 shares; 2025Q1: 1,516,303 shares; 2025Q2: 1,259,749 shares; 2025Q3: 1,259,749 shares; 2025Q4: 1,448,420 shares; 2026Q1: 1,673,420 shares; 2026Q2: 1,673,420 shares; 2026Q3: 1,648,420 shares 1,648,420$67M18.4%-25,000Timeline
PBYIPUMA BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,940,052 shares; 2025Q1: 3,940,052 shares; 2025Q2: 4,131,299 shares; 2025Q3: 4,131,299 shares; 2025Q4: 4,131,299 shares; 2026Q1: 4,131,299 shares; 2026Q2: 4,131,299 shares; 2026Q3: 4,131,299 shares 4,131,299$41M11.27%0Timeline
CADLCANDEL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,939,644 shares; 2025Q1: 2,152,252 shares; 2025Q2: 2,580,517 shares; 2025Q3: 2,580,517 shares; 2025Q4: 2,580,517 shares; 2026Q1: 3,497,948 shares; 2026Q2: 3,497,948 shares; 2026Q3: 3,497,948 shares 3,497,948$36.5M10.03%0Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,001,048 shares; 2025Q1: 2,144,844 shares; 2025Q2: 2,144,844 shares; 2025Q3: 2,144,844 shares; 2025Q4: 2,144,844 shares; 2026Q1: 2,144,844 shares; 2026Q2: 2,144,844 shares; 2026Q3: 2,144,844 shares 2,144,844$30.7M8.44%0Timeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 734,393 shares; 2025Q1: 734,394 shares; 2025Q2: 734,394 shares; 2025Q3: 734,394 shares; 2025Q4: 1,573,023 shares; 2026Q1: 1,540,266 shares; 2026Q2: 1,540,266 shares; 2026Q3: 1,540,266 shares 1,540,266$18.9M5.2%0Timeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 786,760 shares; 2026Q2: 986,760 shares; 2026Q3: 986,760 shares 986,760$13.9M3.81%0Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 643,381 shares; 2025Q1: 643,382 shares; 2025Q2: 643,382 shares; 2025Q3: 643,382 shares; 2025Q4: 643,382 shares; 2026Q1: 643,382 shares; 2026Q2: 643,381 shares; 2026Q3: 668,381 shares 668,381$12.4M3.42%+25,000Timeline
VSTMVERASTEM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 779,498 shares; 2025Q1: 779,498 shares; 2025Q2: 779,498 shares; 2025Q3: 779,498 shares; 2025Q4: 1,469,153 shares; 2026Q1: 1,469,153 shares; 2026Q2: 1,469,153 shares; 2026Q3: 1,469,153 shares 1,469,153$11.8M3.25%0Timeline
OKURONKURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,439,674 shares; 2025Q1: 1,439,674 shares; 2025Q2: 2,839,674 shares; 2025Q3: 2,839,674 shares; 2025Q4: 2,839,674 shares; 2026Q1: 2,839,674 shares; 2026Q2: 2,839,674 shares; 2026Q3: 2,839,674 shares 2,839,674$7.75M2.13%0Timeline
ENGNENGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,271,257 shares; 2026Q3: 3,811,782 shares 3,811,782$7.62M2.09%+2,540,525Timeline
ANTXAN2 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,300,000 shares 1,300,000$6.92M1.9%newTimeline
AURAAURA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 590,508 shares; 2025Q2: 595,744 shares; 2025Q3: 595,744 shares; 2025Q4: 595,744 shares; 2026Q1: 595,744 shares; 2026Q2: 929,077 shares; 2026Q3: 1,025,349 shares 1,025,349$6.44M1.77%+96,272Timeline
TARAPROTARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,279,800 shares; 2025Q1: 1,279,800 shares; 2025Q2: 1,752,115 shares; 2025Q3: 1,752,115 shares; 2025Q4: 1,752,115 shares; 2026Q1: 1,752,115 shares; 2026Q2: 1,752,115 shares; 2026Q3: 1,752,115 shares 1,752,115$5.34M1.47%0Timeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,136,974 shares 1,136,974$4.81M1.32%newTimeline
LONALEONABIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 501,739 shares; 2026Q1: 634,539 shares; 2026Q2: 634,539 shares; 2026Q3: 1,144,416 shares 1,144,416$4.09M1.12%+509,877Timeline
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,147,052 shares; 2025Q1: 1,139,363 shares; 2025Q2: 1,139,363 shares; 2025Q3: 1,139,363 shares; 2025Q4: 1,139,363 shares; 2026Q1: 1,139,363 shares; 2026Q2: 1,139,363 shares; 2026Q3: 932,139 shares 932,139$3.5M0.96%-207,224Timeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 803,425 shares; 2025Q1: 803,425 shares; 2025Q2: 803,425 shares; 2025Q3: 803,425 shares; 2025Q4: 493,425 shares; 2026Q1: 315,052 shares; 2026Q2: 216,171 shares; 2026Q3: 216,171 shares 216,171$1.79M0.49%0Timeline
KPTIKARYOPHARM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 287,826 shares; 2026Q2: 1,518,113 shares; 2026Q3: 1,222,019 shares 1,222,019$1.49M0.41%-296,094Timeline
JSPRJASPER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,382,640 shares; 2025Q4: 1,786,492 shares; 2026Q1: 1,411,492 shares; 2026Q2: 1,438,159 shares; 2026Q3: 1,438,159 shares 1,438,159$834K0.23%0Timeline
VYNEVYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 456,970 shares; 2025Q1: 785,938 shares; 2025Q2: 736,572 shares; 2025Q3: 586,572 shares; 2025Q4: 1,425 shares; 2026Q1: 1,425 shares; 2026Q2: 1,425 shares; 2026Q3: 32,005 shares 32,005$721K0.2%+30,580Timeline
BCABBIOATLA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,032,046 shares; 2025Q1: 4,032,046 shares; 2025Q2: 4,835,111 shares; 2025Q3: 4,835,111 shares; 2025Q4: 4,835,111 shares; 2026Q1: 5,406,345 shares; 2026Q2: 108,126 shares; 2026Q3: 108,127 shares 108,127$141K0.04%+1Timeline

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001636587-26-000102 base2026-11-16